These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16816850)

  • 21. Protective immunity afforded by inactivated H5N1 (NIBRG-14) vaccine requires antibodies against both hemagglutinin and neuraminidase in mice.
    Takahashi Y; Hasegawa H; Hara Y; Ato M; Ninomiya A; Takagi H; Odagiri T; Sata T; Tashiro M; Kobayashi K
    J Infect Dis; 2009 Jun; 199(11):1629-37. PubMed ID: 19385735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. One step closer to universal influenza epitopes.
    Li OT; Poon LL
    Expert Rev Anti Infect Ther; 2009 Aug; 7(6):687-90. PubMed ID: 19681695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of twenty rapid antigen tests for the detection of human influenza A H5N1, H3N2, H1N1, and B viruses.
    Taylor J; McPhie K; Druce J; Birch C; Dwyer DE
    J Med Virol; 2009 Nov; 81(11):1918-22. PubMed ID: 19774693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant modified vaccinia virus Ankara expressing the hemagglutinin gene confers protection against homologous and heterologous H5N1 influenza virus infections in macaques.
    Kreijtz JH; Suezer Y; de Mutsert G; van den Brand JM; van Amerongen G; Schnierle BS; Kuiken T; Fouchier RA; Löwer J; Osterhaus AD; Sutter G; Rimmelzwaan GF
    J Infect Dis; 2009 Feb; 199(3):405-13. PubMed ID: 19061423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuraminidase antibodies and H5N1: geographic-dependent influenza epidemiology could determine cross-protection against emerging strains.
    Bermejo-Martin JF; Kelvin DJ; Guan Y; Chen H; Perez-Breña P; Casas I; Arranz E; de Lejarazu RO
    PLoS Med; 2007 Jun; 4(6):e212. PubMed ID: 17593897
    [No Abstract]   [Full Text] [Related]  

  • 26. Different neutralization efficiency of neutralizing monoclonal antibodies against avian influenza H5N1 virus to virus strains from different hosts.
    Huang H; Dan H; Zhou Y; Yu Z; Fan H; Tong T; Jin M; Chen H
    Mol Immunol; 2007 Feb; 44(5):1052-5. PubMed ID: 16965815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.
    Shi H; Liu XF; Zhang X; Chen S; Sun L; Lu J
    Vaccine; 2007 Oct; 25(42):7379-84. PubMed ID: 17870216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenicity, safety, and cross-reactivity of an inactivated, adjuvanted, prototype pandemic influenza (H5N1) vaccine: a phase II, double-blind, randomized trial.
    Wu J; Fang HH; Chen JT; Zhou JC; Feng ZJ; Li CG; Qiu YZ; Liu Y; Lu M; Liu LY; Dong SS; Gao Q; Zhang XM; Wang N; Yin WD; Dong XP
    Clin Infect Dis; 2009 Apr; 48(8):1087-95. PubMed ID: 19281330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children.
    Nolan T; Richmond PC; Formica NT; Höschler K; Skeljo MV; Stoney T; McVernon J; Hartel G; Sawlwin DC; Bennet J; Ryan D; Basser RL; Zambon MC
    Vaccine; 2008 Nov; 26(50):6383-91. PubMed ID: 18801398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the potency, optimal antigen level and lasting immunity of inactivated avian influenza vaccine prepared from H5N1 virus.
    Sasaki T; Isoda N; Soda K; Sakamoto R; Saijo K; Hagiwara J; Kokumai N; Ohgitani T; Imamura T; Sawata A; Lin Z; Sakoda Y; Kida H
    Jpn J Vet Res; 2009 Feb; 56(4):189-98. PubMed ID: 19358446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Live vaccination with an H5-hemagglutinin-expressing infectious laryngotracheitis virus recombinant protects chickens against different highly pathogenic avian influenza viruses of the H5 subtype.
    Pavlova SP; Veits J; Mettenleiter TC; Fuchs W
    Vaccine; 2009 Aug; 27(37):5085-90. PubMed ID: 19573638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Development of methods for detection of H5N1 from human clinical specimens].
    Wen LY; Xu H; Lan Y; Zhao X; Zhang XG; Wang DY; Yao LH; Dong J; Zhang JH; Guo YJ; Shu YL
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Jun; 20(2):24-6. PubMed ID: 16816856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hemagglutination inhibition test for retrospective diagnosis of avian influenza in mammals].
    Kurskaia OG; Durymanov AG; Sharshov KA; Zaĭkovskaia AV; Shestopalov AM; Il'icheva TN
    Zh Mikrobiol Epidemiol Immunobiol; 2009; (5):75-9. PubMed ID: 20063797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid diagnosis of H5N1 avian influenza virus infection by newly developed influenza H5 hemagglutinin gene-specific loop-mediated isothermal amplification method.
    Imai M; Ninomiya A; Minekawa H; Notomi T; Ishizaki T; Van Tu P; Tien NT; Tashiro M; Odagiri T
    J Virol Methods; 2007 May; 141(2):173-80. PubMed ID: 17218021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A commercial ELISA detects high levels of human H5 antibody but cross-reacts with influenza A antibodies.
    Stelzer-Braid S; Wong B; Robertson P; Lynch GW; Laurie K; Shaw R; Barr I; Selleck PW; Baleriola C; Escott R; Katsoulotos G; Rawlinson WD
    J Clin Virol; 2008 Oct; 43(2):241-3. PubMed ID: 18675584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A simple and rapid immunochromatographic strip test for monitoring antibodies to H5 subtype Avian Influenza Virus.
    Cui S; Chen C; Tong G
    J Virol Methods; 2008 Sep; 152(1-2):102-5. PubMed ID: 18606190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preclinical evaluation of a modified vaccinia virus Ankara (MVA)-based vaccine against influenza A/H5N1 viruses.
    Kreijtz JH; Suezer Y; de Mutsert G; van den Brand JM; van Amerongen G; Schnierle BS; Kuiken T; Fouchier RA; Löwer J; Osterhaus AD; Sutter G; Rimmelzwaan GF
    Vaccine; 2009 Oct; 27(45):6296-9. PubMed ID: 19840663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical detection of Influenza virus infection in formalin-fixed tissues with anti-H5 monoclonal antibody recognizing FFWTILKP.
    He F; Du Q; Ho Y; Kwang J
    J Virol Methods; 2009 Jan; 155(1):25-33. PubMed ID: 18930768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serological reports of human infections of H7 and H9 avian influenza viruses in northern China.
    Jia N; de Vlas SJ; Liu YX; Zhang JS; Zhan L; Dang RL; Ma YH; Wang XJ; Liu T; Yang GP; Wen QL; Richardus JH; Lu S; Cao WC
    J Clin Virol; 2009 Mar; 44(3):225-9. PubMed ID: 19186101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The application of radial hemolysis technique in detection of antibodies to avian influenza virus A (H5N1) and pandemic virus A (H1N1) pdm09].
    Voĭtsekhovskaia EM; Vakin VS; Vasil'eva AA; Kuznetsova EV; Krivitskaia VZ; Sominina AA
    Klin Lab Diagn; 2012 Dec; (12):28-31. PubMed ID: 23479970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.